tiprankstipranks
Advertisement
Advertisement
Adaptive Biotechnologies price target raised to $25 from $22 at Guggenheim
PremiumThe FlyAdaptive Biotechnologies price target raised to $25 from $22 at Guggenheim
22d ago
Analyst Reaffirms Buy on Adaptive Biotechnologies, Lifting Price Target to $25 Amid Strong MRD Momentum and Raised 2026 Guidance
Premium
Ratings
Analyst Reaffirms Buy on Adaptive Biotechnologies, Lifting Price Target to $25 Amid Strong MRD Momentum and Raised 2026 Guidance
22d ago
Adaptive Biotechnologies Earns Buy Rating as Strong MRD-Driven Revenue Beat and Margin Expansion Support Attractive Risk-Reward
Premium
Ratings
Adaptive Biotechnologies Earns Buy Rating as Strong MRD-Driven Revenue Beat and Margin Expansion Support Attractive Risk-Reward
22d ago
Adaptive Biotechnologies price target raised to $20 from $18 at Morgan Stanley
PremiumThe FlyAdaptive Biotechnologies price target raised to $20 from $18 at Morgan Stanley
1M ago
Adaptive Biotechnologies price target raised to $22 from $21 at Guggenheim
Premium
The Fly
Adaptive Biotechnologies price target raised to $22 from $21 at Guggenheim
2M ago
Adaptive Biotechnologies Issues Convertible Notes to Reshape Capital
Premium
Company Announcements
Adaptive Biotechnologies Issues Convertible Notes to Reshape Capital
2M ago
Adaptive to plans to separate minimal residual disease, immune medicine segments
PremiumThe FlyAdaptive to plans to separate minimal residual disease, immune medicine segments
2M ago
Adaptive Biotechnologies Shareholders Back Board, Pay and Auditor
Premium
Company Announcements
Adaptive Biotechnologies Shareholders Back Board, Pay and Auditor
2M ago
Adaptive Biotechnologies price target lowered to $18 from $21 at Morgan Stanley
Premium
The Fly
Adaptive Biotechnologies price target lowered to $18 from $21 at Morgan Stanley
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100